Literature DB >> 22735838

Rheumatoid arthritis: GO-FURTHER with intravenous golimumab for active RA.

Sarah Onuora.   

Abstract

Entities:  

Year:  2012        PMID： 22735838     DOI： 10.1038/nrrheum.2012.101

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial.

Authors:  Michael E Weinblatt; Clifton O Bingham; Alan M Mendelsohn; Lilianne Kim; Michael Mack; Jiandong Lu; Daniel Baker; Rene Westhovens
Journal:  Ann Rheum Dis       Date:  2012-06-01       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.